THE PERSHING SQUARE SOHN PRIZE AWARDED TO FIVE EMERGING LEADERS IN CANCER RESEARCH The Pershing Square Foundation Has Committed More Than $43 Million to 71 Scientists in the Greater New York Area to Support High-Risk, High-Reward Cancer Research NEW YORK, JUNE 4, 2024 (Business Wire) – The Pershing Square Sohn Cancer Research Alliance today announced … Continued
CSHL (February 14, 2024) — Scientists at Cold Spring Harbor Laboratory (CSHL) and the University of California, Davis have reached a new breakthrough in pancreatic cancer research—eight years in the making. It could help slow the disease’s deadly spread. In 2017, as a postdoc in CSHL’s Tuveson lab, Chang-il Hwang and collaborators from the Vakoc lab uncovered … Continued
THE PERSHING SQUARE SOHN CANCER RESEARCH ALLIANCE IS NOW ACCEPTING APPLICATIONS FOR ITS 2024 PRIZE FOR RISING LEADERS IN CANCER RESEARCH NEW YORK, SEPTEMBER 25, 2023 (The Pershing Square Foundation, Business Wire) — The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2024 Pershing Square Sohn Prize for … Continued
SciTech Daily –New York, NY (July 31, 2023) — New recent research from Yale has discovered a method to control the self-destructive tendencies of certain killer T cells utilized in cancer therapy. CAR T-cell (chimeric antigen receptor) therapy, a promising form of immunotherapy, involves reprogramming the patient’s T cells to enhance their ability to identify … Continued
The Rockefeller University – When we’re driving to a new destination, we often turn down the stereo as we follow the directions. What had been music suddenly sounds like noise, and it interferes with our focus. Our understanding of how infectious diseases like COVID affect human lungs has been similarly confounded by noise. Data from … Continued
Icahn School of Medicine at Mt. Sinai – Recent work with induced pluripotent stem cells has helped uncover complex mechanisms in myelodysplastic syndrome and acute myeloid leukemia for the first time. This discovery could pave the way for improving current treatments, or even for finding new ones. A decade ago, somatic mutations—those that occur after … Continued
CT Insider — New Haven, CT (February 21, 2023) A new gene editing technique developed by scientists from Yale University offers a powerful new tool to interrogate how genes work across a swath of biological disciplines, from cancer research to immunology. According to a study published in Nature Biotechnology, the technique called “CLASH” allows potentially thousands … Continued
The Pershing Square Sohn Cancer Research Alliance Is Now Accepting Applications for its 2023 Prize for Radically Innovative, Early-Career Cancer Researchers NEW YORK, OCTOBER 3, 2022 (Business Wire) – The Pershing Square Sohn Cancer Research Alliance (PSSCRA) today announced the opening of applications for the 2023 Pershing Square Sohn Prize for Young Investigators in Cancer … Continued
Colorectal tumors are swarming with white blood cells, but whether these cells help or hinder the cancer is hotly debated. While some studies have shown that white blood cells heroically restrict tumor growth and combat colorectal cancer, equally compelling evidence casts the white blood cells as malignant co-conspirators—bolstering the tumor and helping it spread. Now, … Continued
Newswise — New York, NY (April 6, 2022)— Mutation of a gene called ARID2 plays a role in increasing the chance that melanoma, a deadly skin cancer, will turn dangerously metastatic, Mount Sinai researchers report. The findings suggest that patients whose melanoma tumors have an ARID2 mutation may have a more aggressive cancer and may need to be treated … Continued